Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, indicating a minor version update in the study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 has been added and Revision: v3.4.0 has been removed, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedA glossary display was added; the footer now includes Revision: v3.4.0 and capitalization was corrected for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 is now shown, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study location section now lists new sites across Brazil, China, and South Korea (and other regions), and some previously listed locations have been removed.SummaryDifference2%

- Check92 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2, a minor maintenance change that does not affect any study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.